Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 May;64(2):442–449.

Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures.

T Hunziker, U E Nydegger, P G Lerch, J D Vassalli
PMCID: PMC1542357  PMID: 3742881

Abstract

Supernatant fluids were prepared from human platelets (2-2.5 X 10(10)/ml) after sonication of stimulation with cross-linked IgG; together with plasma samples from two patients with different types of pemphigus, they enhanced acantholysis in cultured punch biopsy specimens of human skin. In the absence of pemphigus plasma the platelet-derived materials did not induce acantholysis. The acantholysis-enhancing effect persisted after exhaustive dialysis or heating (56 degrees C, 30 min). The platelet-derived materials did not contain plasminogen activator; plasminogen itself was detectable by zymographic analysis, although in quantities too low (0.2-0.5 micrograms/ml) to account for the acantholysis-enhancing activity. We conclude that the platelet could contribute to the pathogenesis of pemphigus. The nature of the platelet-derived acantholysis-enhancing factors is presently unknown.

Full text

PDF
442

Images in this article

444Fig. 1
on p.444
447Fig. 2
on p.447

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed A. R., Ank B. J., Gard S. E., Stiehm E. R. Bactericidal activity and chemotaxis in pemphigus vulgaris and bullous pemphigoid. J Am Acad Dermatol. 1982 Jun;6(6):1028–1033. doi: 10.1016/s0190-9622(82)70087-8. [DOI] [PubMed] [Google Scholar]
  2. Ahmed A. R., Moy R. L., Chia D., Barnett E. V. Immune complexes in pemphigus and bullous pemphigoid. Dermatologica. 1983;166(4):175–180. doi: 10.1159/000249863. [DOI] [PubMed] [Google Scholar]
  3. Archer C. B., Page C. P., Paul W., Morley J., MacDonald D. M. Inflammatory cell accumulation in response to intracutaneous Paf-acether: a mediator of acute and persistent inflammation? Br J Dermatol. 1985 Jul;113 (Suppl 28):133–135. doi: 10.1111/j.1365-2133.1985.tb15642.x. [DOI] [PubMed] [Google Scholar]
  4. BETTEX-GALLAND M., LUSCHER E. F. Studies on the metabolism of human blood platelets in relation to clot retraction. Thromb Diath Haemorrh. 1960 Mar 1;4:178–195. [PubMed] [Google Scholar]
  5. Erickson L. A., Ginsberg M. H., Loskutoff D. J. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest. 1984 Oct;74(4):1465–1472. doi: 10.1172/JCI111559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fitzmaurice M., Deodhar S. D. Pemphigus and pemphigoid antibody production by pokeweed mitogen-stimulated peripheral blood mononuclear cell cultures in vitro. Am J Clin Pathol. 1984 May;81(5):586–590. doi: 10.1093/ajcp/81.5.586. [DOI] [PubMed] [Google Scholar]
  7. Granelli-Piperno A., Reich E. A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med. 1978 Jul 1;148(1):223–234. doi: 10.1084/jem.148.1.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gross B., Haessig A., Luescher E. F., Nydegger U. E. Monomeric IgG preparations for intravenous use inhibit platelet stimulation by polymeric IgG. Br J Haematol. 1983 Feb;53(2):289–299. doi: 10.1111/j.1365-2141.1983.tb02023.x. [DOI] [PubMed] [Google Scholar]
  9. Hashimoto K., Shafran K. M., Webber P. S., Lazarus G. S., Singer K. H. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med. 1983 Jan 1;157(1):259–272. doi: 10.1084/jem.157.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hashimoto K., Singer K., Lazarus G. S. Penicillamine-induced pemphigus. Immunoglobulin from this patient induces plasminogen activator synthesis by human epidermal cells in culture: mechanism for acantholysis in pemphigus. Arch Dermatol. 1984 Jun;120(6):762–764. doi: 10.1001/archderm.120.6.762. [DOI] [PubMed] [Google Scholar]
  11. Hashimoto K., Singer K., Lazarus G. S. The effect of corticosteroids, dapsone and gold upon plasminogen activator synthesis and secretion by human epidermal cells cultured with pemphigus antibody. Br J Dermatol. 1984 Mar;110(3):293–297. doi: 10.1111/j.1365-2133.1984.tb04634.x. [DOI] [PubMed] [Google Scholar]
  12. Hunziker T., Nydegger U. E., Späth P. J., Gerber H. A., Hess M., Wiesmann U., Krebs A. High doses of antigen-nonspecific IgG do not inhibit pemphigus acantholysis in skin organ cultures. Arch Dermatol Res. 1985;277(4):299–303. doi: 10.1007/BF00509084. [DOI] [PubMed] [Google Scholar]
  13. Issekutz A. C., Ripley M., Jackson J. R. Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest. 1983 Dec;49(6):716–724. [PubMed] [Google Scholar]
  14. Iwatsuki K., Tagami H., Yamada M. Pemphigus antibodies mediate the development of an inflammatory change in the epidermis. A possible mechanism underlying the feature of eosinophilic spongiosis. Acta Derm Venereol. 1983;63(6):495–500. [PubMed] [Google Scholar]
  15. Jeffes E. W., 3rd, Kaplan R. P., Ahmed A. R. Acantholysis produced in vitro with pemphigus serum: hydrocortisone inhibits acantholysis, while dapsone and 6-mercaptopurine do not inhibit acantholysis. J Clin Immunol. 1984 Sep;4(5):359–363. doi: 10.1007/BF00917138. [DOI] [PubMed] [Google Scholar]
  16. King A. J., Schwartz S. A., Lopatin D., Voorhees J. J., Diaz L. A. Suppressor cell function is preserved in pemphigus and pemphigoid. J Invest Dermatol. 1982 Sep;79(3):183–185. doi: 10.1111/1523-1747.ep12500052. [DOI] [PubMed] [Google Scholar]
  17. Mahrle G., Patyk H., Bolling R. Concanavalin-A binding sites, pemphigus antigens, and beta 2 microglobulin in epidermal hyperproliferation, premalignant and malignant lesions. Arch Dermatol Res. 1982;274(1-2):85–92. doi: 10.1007/BF00510362. [DOI] [PubMed] [Google Scholar]
  18. Miyagawa S., Sakamoto K. Characterization of cryoprecipitates in pemphigus: demonstration of pemphigus antibody activity in cryoprecipitates using the immunofluorescent technique. J Invest Dermatol. 1977 Oct;69(4):373–375. doi: 10.1111/1523-1747.ep12510253. [DOI] [PubMed] [Google Scholar]
  19. Murahata R. I., Ahmed A. R. Detection of class-specific antibodies of pemphigus vulgaris using a solid phase radioimmunoassay. J Invest Dermatol. 1982 Aug;79(2):65–68. doi: 10.1111/1523-1747.ep12500026. [DOI] [PubMed] [Google Scholar]
  20. Peterson L. L., Wuepper K. D. Isolation and purification of a pemphigus vulgaris antigen from human epidermis. J Clin Invest. 1984 Apr;73(4):1113–1120. doi: 10.1172/JCI111297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pfueller S. L., Weber S., Lüscher E. F. Studies of the mechanism of the human platelet release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma. J Immunol. 1977 Feb;118(2):514–524. [PubMed] [Google Scholar]
  22. Razzaque Ahmed A. Diagnosis of bullous disease and studies in the pathogenesis of blister formation using immunopathological techniques. J Cutan Pathol. 1984 Aug;11(4):237–248. doi: 10.1111/j.1600-0560.1984.tb00374.x. [DOI] [PubMed] [Google Scholar]
  23. Rickli E. E., Cuendet P. A. Isolation of plasmin-free human plasminogen with N-terminal glutamic acid. Biochim Biophys Acta. 1971 Nov 13;250(2):447–451. doi: 10.1016/0005-2744(71)90202-6. [DOI] [PubMed] [Google Scholar]
  24. Ruocco V., de Luca M., Pisani M., de Angelis E., Vitale O., Astarita C. Pemphigus provoked by D(-)penicillamine. An experimental approach using in vitro tissue cultures. Dermatologica. 1982 Apr;164(4):236–248. [PubMed] [Google Scholar]
  25. SARKANY I., GRICE K., CARON G. A. ORGAN CULTURE OF ADULT HUMAN SKIN. Br J Dermatol. 1965 Feb;77:65–76. doi: 10.1111/j.1365-2133.1965.tb14602.x. [DOI] [PubMed] [Google Scholar]
  26. Sbano E., Andreassi L., Fimiani M., Baiocchi R., Biagioli M. Pemphigus antibodies fixation and keratinocyte differentiation in organ cultures. Effects of some agents influencing the intracellular content of cyclic AMP. Arch Dermatol Res. 1982;273(1-2):9–14. doi: 10.1007/BF00509022. [DOI] [PubMed] [Google Scholar]
  27. Schiltz J. R., Hu C. H., Michel B. Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody-induced acantholysis in vitro. Br J Dermatol. 1979 Sep;101(3):279–284. doi: 10.1111/j.1365-2133.1979.tb05620.x. [DOI] [PubMed] [Google Scholar]
  28. Singer K. H., Hashimoto K., Jensen P. J., Morioka S., Lazarus G. S. Pathogenesis of autoimmunity in pemphigus. Annu Rev Immunol. 1985;3:87–108. doi: 10.1146/annurev.iy.03.040185.000511. [DOI] [PubMed] [Google Scholar]
  29. Stanley J. R., Koulu L., Thivolet C. Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest. 1984 Aug;74(2):313–320. doi: 10.1172/JCI111426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Swanson D. L., Dahl M. V. Methylprednisolone inhibits pemphigus acantholysis in skin cultures. J Invest Dermatol. 1983 Sep;81(3):258–260. doi: 10.1111/1523-1747.ep12518278. [DOI] [PubMed] [Google Scholar]
  31. Tappeiner G., Heine K. G., Kahl J. C., Jordon R. E. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay. Clin Exp Immunol. 1977 Apr;28(1):40–48. [PMC free article] [PubMed] [Google Scholar]
  32. Thivolet C. H., Hintner H. H., Stanley J. R. The effect of retinoic acid on the expression of pemphigus and pemphigoid antigens in cultured human keratinocytes. J Invest Dermatol. 1984 Apr;82(4):329–334. doi: 10.1111/1523-1747.ep12260634. [DOI] [PubMed] [Google Scholar]
  33. Valone F. H., Austen K. F., Goetzl E. J. Identification of the platelet activating activity in rheumatoid synovial fluid as an intermediate molecular weight complex of IgG. J Immunol. 1979 Feb;122(2):703–709. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES